KRAS and neoplasm: At the molecular level, the activation of the MAPK pathway (either by KRAS or BRAF mutation), the prominent EMT (not involving nuclear β-catenin expression) and the frequent CIMP-H status are characteristic of the tumor itself, whereas the abundance of microvascular density and the weak immune response are common features of the surrounding tumor microenvironment.